Search company, investor...


Founded Year



Grant - IV | Alive

Total Raised


Last Raised

$800K | 3 mos ago

About Sleepiz

Sleepiz makes a wireless device that measures vital signs without touching the patient, enabling non-contact home diagnosis of sleep apnea. It offers remote patient monitoring, apnea screening, sleep analytics AI, patient-centric health monitoring, and other life sciences services. The company was founded in 2017 and is based in Zurich, Switzerland.

Headquarters Location

Hornbachstrasse 23

Zurich, 8008,


+41 44 586 08 88

Sleepiz's Product Videos

ESPs containing Sleepiz

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Biopharma Tech

These companies use wearable devices and other portable sensors to track brain activity, eye movements, and facial movements to assess sleep quality.

Sleepiz named as Outperformer among 4 other companies, including EnsoData, Dozee, and Wesper.

Compete with Sleepiz?

Ensure that your company and products are accurately represented on our platform.

Sleepiz's Products & Differentiators

    Sleepiz One

    CE Class I device, measures basic movement parameters of a patient

Research containing Sleepiz

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Sleepiz in 2 CB Insights research briefs, most recently on Dec 19, 2022.

Expert Collections containing Sleepiz

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sleepiz is included in 9 Expert Collections, including Wellness Tech.


Wellness Tech

1,370 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.


Sleep Health & Wellness

802 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.


Medical Devices

8,606 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

3,466 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,306 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest Sleepiz News

Sleepiz secures EUR 800,000 in funding and joins the largest U.S. telemedicine organization

Oct 27, 2022

27.10.2022 ETH spinoff Sleepiz is joining the American Telehealth Association (ATA) after registering its Sleepiz One+ device with the FDA in July. Membership will give the company access to a broad network of tech vendors, investors, healthcare institutions, industry experts, and policymakers. The startup has also received funding of EUR 800,000 as part of a European research project. Sleepiz participated in Venture Kick in 2017 and made the TOP 100 Swiss Startup ranking in 2022. The compan's founders (from left to right): Max Sieghold (CFO), Soumya Dash (CEO), and Marc Rullan (CTO) The Swiss medtech startup Sleepiz registered Sleepiz One+— a device for the contactless measurement of respiration and heart rate—with the U.S. Food and Drug Administration (FDA) in July. Now, Sleepiz is joining the ATA, a broad-based network of leading academic institutions, technology solution providers, investors, and healthcare institutions dedicated to advancing telemedicine in the United States. "Membership with the ATA gives us the opportunity to raise awareness of Sleepiz's technology in U.S. and global markets," said Robb LaChapelle, Sleepiz's vice president in the U.S. Sleepiz CEO Soumya Dash said, "This is an important step in bringing the benefits of our technology to patients, physicians and researchers, expanding the company's success into foreign markets." Sleepiz also received EUR 800,000 from the European Active Assisted Leaving program to co-design a platform for the remote monitoring of nocturnal vital signs for the diagnosis, management, and prediction of chronic respiratory diseases in the elderly. The project aims to provide access to state-of-the-art healthcare for the elderly and chronically ill; it's carried out in collaboration with the Swiss Terz Foundation, In4Care Happy Aging from Belgium, and the leading medical informatics research group at Aalborg University in Denmark. Max Sieghold, co-founder of Sleepiz, said, "This partnership gives us the opportunity to warn patients about deteriorating health before it becomes acute. "    Sleepiz One+ is one of the first respiratory monitoring devices to capture and record patient data during sleep without contact. The technology enables entirely new insights into patient health, as physicians no longer have to rely on random measurements, but gain access to continuous data. Physicians in the U.S. can prescribe Sleepiz One+ to their patients to measure their vital signs in the short and long term, providing greater insight into patients' physiological status. For patients, Sleepiz One+ provides a new and convenient way to take continuous measurements at home by simply placing a small device on their bedside table before bed. Sleepiz participated in the Venture Kick program in 2017, winning CHF 10,000 to accelerate the startup's growth. The company was voted one of 2022's TOP 100 Swiss Startup s by investors and experts. In 2020, it won the TOP 100 Public Vote . The company's founders (from left to right): Max Sieghold (CFO), Soumya Dash (CEO), and Marc Rullan (CTO)

Sleepiz Frequently Asked Questions (FAQ)

  • When was Sleepiz founded?

    Sleepiz was founded in 2017.

  • Where is Sleepiz's headquarters?

    Sleepiz's headquarters is located at Hornbachstrasse 23, Zurich.

  • What is Sleepiz's latest funding round?

    Sleepiz's latest funding round is Grant - IV.

  • How much did Sleepiz raise?

    Sleepiz raised a total of $11.7M.

  • Who are the investors of Sleepiz?

    Investors of Sleepiz include Active Assisted Living Programme, Verve Ventures VC, Zurcher Kantonalbank, Horizon 2020, EIT Health and 14 more.

  • Who are Sleepiz's competitors?

    Competitors of Sleepiz include Rimidi, Dozee, Monogram Health, Aluna, BrainCheck, Wesper, NeuroFlow, Vessel, Lifelight, WellSense and 93 more.

  • What products does Sleepiz offer?

    Sleepiz's products include Sleepiz One and 1 more.

Compare Sleepiz to Competitors

BioIntelliSense Logo

BioIntelliSense develops a clinical intelligence platform. The platform offers continuous health monitoring, predictive analytics, and algorithmic clinical insights. It also offers medical-grade monitoring services through its sensor-enabled skin-wearing device which performs analytics and data services for early detection of skin temperature, heart rate, respiratory rate, fall detection, coughing sneezing, and vomiting frequency to channel real-time data to the platform, helping hospitals assess vital signs, physiological biometrics and symptomatic events of patients. The company was founded in 2018 and is based in Golden, Colorado.

Biofourmis Logo

Biofourmis discovers, develops, and delivers clinically-validated, software-based therapeutics. Biofourmis has built Biovitals, a personalized, AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of its digital therapeutics product pipeline across multiple therapeutic areas, including heart failure, oncology, acute coronary syndrome, COPD, and chronic pain. It serves clients operating in the healthcare sector. The company was founded in 2015 and is based in Boston, Massachusetts.

Withings Logo

Withings creates smart products and apps to help people across the world take care of their health and well-being. By extending the capabilities of an object through network resources, Withings provides access to computing and storage facility at no extra cost, turning objects into smart connected devices.


AiCure is an AI and advanced data analytics company targeting the health care industry. AiCure uses AI to see, hear and understand how people respond to treatment across clinical trials and patient care. Clinically proven to accurately measure and modify patient behavior, AiCure’s technologies keep patients engaged and optimized to treatment, as well as assess treatment effectiveness.

Somatix Logo

Somatix is a provider of wearable-enabled RPM (Remote Patient Monitoring) software platforms for healthcare. Its cost-effective solution uses patented gesture detection technology and machine learning algorithms to analyze user's gesture data in real-time. The algorithms remotely and passively detect physical and emotional indicators for generating insights on risk factors for adverse events, poor medical compliance, inactivity, falls, dehydration, and more.

Swift Medical Logo
Swift Medical

Swift Medical develops wound care management software. Swift Medical's mobile app captures wound care information. The company provides immediate tissue analytics using proprietary machine vision algorithms.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.